sulfamethoxazole has been researched along with Dermatomyositis, Adult Type in 1 studies
Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, L | 1 |
| Zhang, Y | 1 |
| Liu, S | 1 |
| Wang, C | 1 |
| Zhang, L | 1 |
| Guan, W | 1 |
| Zhang, X | 1 |
| Li, W | 1 |
| Shu, X | 1 |
| Li, T | 1 |
1 other study available for sulfamethoxazole and Dermatomyositis, Adult Type
| Article | Year |
|---|---|
Compounded sulfamethoxazole improved the prognosis of dermatomyositis patients positive with anti-melanoma differentiation-associated gene 5.
Topics: Dermatomyositis; Humans; Interferon-Induced Helicase, IFIH1; Prognosis; Retrospective Studies; Sulfa | 2023 |